WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

UPDATES ON EBOLA VIRUS FEVER: DIAGNOSIS AND PROGRESSION IN VACCINE DEVELOPMENT

*Tiwari Ankush S., Yadav K.S., Gomes Merlyn W.

ABSTRACT

Ebola Virus Disease (previously was recognized as Ebola Haemorrhagic Fever) is a Severe, often fatal illness, with a death of up to 90%. The illness affects humans and nonhuman primates (monkeys, gorillas and chimpanzees).[1] Today, West Africa is facing the biggest outbreak of Ebola virus disease (EVD) in history. Of all the viral haemorrhagic fevers, EVD is amongst the most virulent pathogens and case fatality rates up to 90% have been reported for it. Its high pathogenicity and transmissibility and potential to be misused as a bioterrorism agent has threatened the entire world. This review aims to provide an overview for diagnosis and treatment options available currently and those that are under process but have shown promising results for the future. The test available currently for diagnosis includes ELISA, RT-PCR (Real Time-Polymerase Chain Reaction), combination of nucleic acid purification and nested multiplex RT-PCR Film Array (FA) system, nucleic acid sequencing technologies, serum neutralization test, NAT (nucleic acid test) molecular detection, Ebola virus isolation, antigen detection, IgM or IgG antibody detection. While the treatment options currently under clinical trials are DNA vaccines, Ebola VLPs, Vaccinia virus-based vaccine, Venezuelan equine encephalitis virus (VEEV)-like replicon particles, recombinant Zaire Ebolavirus ΔVP30, Kunjin virus-based vaccine, recombinant cytomegalovirus (CMV)- vaccines, recombinant paramyxovirus-vaccines, adenovirus-based vaccines and vesicular stomatitis virus-based vaccines, recombinant rabies virus (RABV)-based vaccines monoclonal antibodies, nucleoside analogues, Phosporodiamidate morpholino oligomer, ribavirin, interferons, recombinant human activated protein C (rhAPC).

Keywords: Ebola virus, RT-PCR, ELISA, Ebola vaccines.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More